NCT05578391View on ClinicalTrials.gov

Passive Immunotherapy In Patients With SARS CoV-2

PHASE2CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

December 31, 2020

Study Completion Date

March 31, 2021

Conditions
COVID-19
Interventions
BIOLOGICAL

Convalescent plasma

Admistration of one unit of convalescent plasma

Trial Locations (1)

36211

Hospital Álvaro Cunqueiro, Vigo

All Listed Sponsors
collaborator

Health Knowledge Agency

UNKNOWN

lead

Fundacin Biomedica Galicia Sur

OTHER

NCT05578391 - Passive Immunotherapy In Patients With SARS CoV-2 | Biotech Hunter | Biotech Hunter